Download PDF
Thromb Haemost 1981; 45(02): 186
DOI: 10.1055/s-0038-1650160
Letter to the Editor
Schattauer GmbH Stuttgart

Further Data about the Clotting Insignificance of Coumarin-lnduced Prefactors

Antonio Girolami
Institute of Semeiotica Medica, University of Padua Medical School, Padua, Italy
› Author Affiliations
Further Information

Publication History

Received 13 October 1980

Accepted 22 January 1981

Publication Date:
05 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Girolami A. Residual factor VII in thromboplastin preparations. Thromb Haemostas 1978; 40: 577
    PubMedGoogle Scholar
  • 2 Stormorken H. Species differences of clotting factor on ox, horse, dog and mouse. Acta Physiol Scand 1957; 41: 01-24
    CrossrefPubMedGoogle Scholar
  • 3 Loeliger EA, Van Halem-VisserL P. Biological properties of the thromboplastins and plasmas included in the ICTH/ICSH collaborative study on prothrombin time standardization. Thromb Haemostas 1979; 42: 1115-1127
    PubMedGoogle Scholar
  • 4 Girolami A, Lazzarin M, Molaro G. The effect of several tissue thromboplastins on the activation of the abnormal factor X (Factor X Friuli). Thromb Diath Haemorrh 1972; 27: 535-542
    PubMedGoogle Scholar
  • 5 Loeliger EA, Hensen A, Mattern MJ, Hemker C. Behaviour of factor II, VII, IX and X in bleeding complications during long term treatment with coumarin. Thromb Diath Haemorrh 1963; 10: 278-281
    PubMedGoogle Scholar
  • 6 Girolami A, Dal BoZanon R, De MarcoL, Cappellato G. Haemophilia B associated factor VII deficiency: a distinct variant of haemophilia B with low factor VII and normal factor VII antigen. Blut 1980; 40: 267
    CrossrefPubMedGoogle Scholar
  • 7 Girolami A, Patrassi GM, Burul A. Thrombotest mixing experiments in congenital coagulation disorders of prothrombin complex and in coumarin treated patients. Fol Haemat 1977; 104: 463-470
    PubMedGoogle Scholar